Warren Buffett’s Berkshire Hathaway Inc. cut two of its payments bets -- holdings in $(Visa)$ Inc. and $(Mastercard)$ Inc. -- as it also pulled back on investments in pharmaceutical giants AbbVie Inc. and Bristol Myers-Squibb Co.
Berkshire reported a 30% decrease in AbbVie and a 16% cut to its Bristol-Myers Squibb investment during the third quarter, as well as no longer showing a stake in Merck & Co., according to a filing released Monday. The Visa and Mastercard holdings were cut 4.3% and 6% respectively.
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
点赞
举报
登录后可参与评论

暂无评论

